Home
Statistics
Acknowledgment
Enquire
Keyword Search
Complex Search
Segment Search
Peptide Mapping
Browse On
Mode of delivery
Animal model
Origin/Source
Peptide Length
Similarity
BLAST Search
Smith-Waterman
General
Help or Guide
Data Submission
Curators
Developers
Contact Us
Browse result page of B3Pdb
The total number entries retrieved from this search are
137
, scroll left/right for detailed information.
B3pdbID
PEPTIDE NAME
PEPTIDE SEQUENCE (1-letter)
PEPTIDE SEQUENCE (3-letter)
N-TERMINAL MODIFICATION
C-TERMINAL MODIFICATION
CHEMICAL MODIFICATION
PEPTIDE LENGTH
PEPTIDE CONFORMATION
PEPTIDE NATURE
SOURCE/ORIGIN OF PEPTIDE
SMILES
CELL LINE
In vitro
CONCENTRATION
In vitro
METHOD
In vitro
RESULT
ANIMAL MODEL
In vivo
CONCENTRATION
In vivo
MODE OF DELIVERY
In vivo
METHOD
In vivo
RESULT
ACTION
TRANSPORT TYPE
SUBCELLULAR LOCALISATION
COMBINATION
PHYSICAL CONDITION
RESPONSE
RESULT
LABEL
PMID
b3pdb_0812
Apidaecin Api137
Guan-ONNRPVYIPRPRPPHPRL
Guan-Orn-Asn-Asn-Arg-Pro-Va-Tyr-Ile-Pro-Arg-Pro-Arg-Pro-Pro-His-Pro-Arg-Leu
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
77%
Direct iodination
24164260
b3pdb_0813
Apidaecin Api137
Guan-ONNRPVYIPRPRPPHPRL
Guan-Orn-Asn-Asn-Arg-Pro-Va-Tyr-Ile-Pro-Arg-Pro-Arg-Pro-Pro-His-Pro-Arg-Leu
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00073 mL/(g x min)
Direct iodination
24164260
b3pdb_0814
Apidaecin Api137
Guan-ONNRPVYIPRPRPPHPRL
Guan-Orn-Asn-Asn-Arg-Pro-Va-Tyr-Ile-Pro-Arg-Pro-Arg-Pro-Pro-His-Pro-Arg-Leu
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.02343 ml/g
Direct iodination
24164260
b3pdb_0873
Dalargin-SS-SynB1
YaGFLR-NHC2H4S-SC2H4NH-RGGRLSYSRRRFSTSTGR-NH2
Tyr-(D)Ala-Gly-Phe-Leu-Arg-NHC2H4S-SC2H4NH-Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-Arg-NH2
NA
NA
Cys-Cys (linker)
20
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.309 ml/g
H3/C14
12682214
b3pdb_0874
Dalargin-SS-SynB3
YaGFLR-C2H4S-SC2H4-RRLSYSRRRF-NH2
Tyr-(D)Ala-Gly-Phe-Leu-Arg-NHC2H4S-SC2H4NH-Arg-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-NH2
NA
NA
Cys-Cys (linker)
16
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.24 ml/g
H3/C14
12682214
b3pdb_0881
Angiopep-1
TFFYGGCRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Cys-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
37.28%
Direct iodination
18156463
b3pdb_0882
Angiopep-1
TFFYGGCRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Cys-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
62.72%
Direct iodination
18156463
b3pdb_0883
Angiopep-1
TFFYGGCRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Cys-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(brain/perfusate)
0.3537 ml/g
Direct iodination
18156463
b3pdb_0884
Angiopep-1
TFFYGGCRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Cys-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(capillary/perfusate)
0.1341 ml/g
Direct iodination
18156463
b3pdb_0885
Angiopep-1
TFFYGGCRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Cys-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(parenchyma/perfusate)
0.2256 ml/g
Direct iodination
18156463
b3pdb_0886
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
% capillary
15.47%
Direct iodination
18156463
b3pdb_0887
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
% parenchyma
84.53%
Direct iodination
18156463
b3pdb_0888
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
% parenchyma
84%
Direct iodination
19818094
b3pdb_0889
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
% capillary
15.63%
Direct iodination
18489712
b3pdb_0890
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
% parenchyma
84.37%
Direct iodination
18489712
b3pdb_0891
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
% capillary
16%
Direct iodination
19818094
b3pdb_0892
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
CD(capillary/perfusate)
0.04 ml/g
Direct iodination
19818094
b3pdb_0893
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
CD(brain/perfusate)
0.24 ml/g
Direct iodination
19818094
b3pdb_0894
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
CD(parenchyma/perfusate)
0.1976 ml/g
Direct iodination
18489712
b3pdb_0895
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
CD(brain/perfusate)
0.2342 ml/g
Direct iodination
18489712
b3pdb_0896
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
CD(parenchyma/perfusate)
0.2 ml/g
Direct iodination
18156463
b3pdb_0897
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
CD(capillary/perfusate)
0.0366 ml/g
Direct iodination
18156463, 18489712
b3pdb_0898
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
CD(brain/perfusate)
0.2317 ml/g
Direct iodination
18156463
b3pdb_0899
Angiopep-2
TFFYGGSRGKRNNFKTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
saturable
NA
NA
NA
CD(parenchyma/perfusate)
0.2 ml/g
Direct iodination
19818094
b3pdb_0900
Angiopep-5
TFFYGGSRGKRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
9.53%
Direct iodination
18156463
b3pdb_0901
Angiopep-5
TFFYGGSRGKRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
90.47%
Direct iodination
18156463
b3pdb_0902
Angiopep-5
TFFYGGSRGKRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(brain/perfusate)
0.1341 ml/g
Direct iodination
18156463
b3pdb_0903
Angiopep-5
TFFYGGSRGKRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(capillary/perfusate)
0.0122 ml/g
Direct iodination
18156463
b3pdb_0904
Angiopep-5
TFFYGGSRGKRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Lys-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(parenchyma/perfusate)
0.1158 ml/g
Direct iodination
18156463
b3pdb_0905
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
% injected dose
0.22 %/g
Direct iodination
29090274
b3pdb_0906
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
55%
Direct iodination
19818094
b3pdb_0907
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
45%
Direct iodination
19818094
b3pdb_0908
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
66.67%
Direct iodination
18156463
b3pdb_0909
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
33.33%
Direct iodination
18156463
b3pdb_0910
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(parenchyma/perfusate)
0.0366 ml/g
Direct iodination
19818094
b3pdb_0911
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(capillary/perfusate)
0.0183 ml/g
Direct iodination
18156463
b3pdb_0912
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(brain/perfusate)
0.061 ml/g
Direct iodination
18156463
b3pdb_0913
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(brain/perfusate)
0.054 ml/g
Direct iodination
19818094
b3pdb_0914
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(capillary/perfusate)
0.024 ml/g
Direct iodination
19818094
b3pdb_0915
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(parenchyma/perfusate)
0.03 ml/g
Direct iodination
18489712
b3pdb_0916
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
NA
NA
NA
NA
% injected dose
0.032 %/g
Direct iodination
29090274
b3pdb_0917
Exendin-4-NH2
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
20.22%
Direct iodination
18489712
b3pdb_0918
Exendin-4-NH2
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
79.78%
Direct iodination
18489712
b3pdb_0919
Exendin-4-NH2
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(brain/perfusate)
0.0183 ml/g
Direct iodination
18489712
b3pdb_0920
Exendin-4-NH2
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(parenchyma/perfusate)
0.0146 ml/g
Direct iodination
18489712
b3pdb_0921
Exendin-4-NH2
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(capillary/perfusate)
0.0037 ml/g
Direct iodination
18489712
b3pdb_0922
Oncocin
VDKPPYLPRPRPPRRIYNR-NH2
Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.002 min-1
Direct iodination
24164260
b3pdb_0923
Oncocin
VDKPPYLPRPRPPRRIYNR-NH2
Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
82%
Direct iodination
24164260
b3pdb_0924
Oncocin
VDKPPYLPRPRPPRRIYNR-NH2
Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
18%
Direct iodination
24164260
b3pdb_0925
Oncocin
VDKPPYLPRPRPPRRIYNR-NH2
Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00044 mL/(g x min)
Direct iodination
24164260
previous
1
2
3
next
IIITD/CB
Raghava's Group
IMTECH
CellPPDMOD